Trials / Terminated
TerminatedNCT01221961
Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
A Study to Determine the Agreement Between Masimo Monitor and Standard of Care
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor); recorded several times throughout patient's major spine surgery procedure (depending on how many times the physician/nurse orders the Hb value to be tested), between the standard clinical practice {intermittent measure of Hb \[Cedar Sinai Medical Center (CSMC) Lab and outside lab) and Masimo radical-7 device (continuous, non-invasive Hb level measurements)\*.
Detailed description
\*See whether or not the hemoglobin values recorded at the same time matches between the standard clinical practice (CSMC Lab and outside Lab) and the Masimo device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Masimo Radical-7 | The Masimo device will be placed on one finger of the patient. To see whether or not the hemoglobin values recorded at the same time matches between the standard clinical practice (CSMC Lab and outside Lab) and the Masimo device |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2010-10-18
- Last updated
- 2013-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01221961. Inclusion in this directory is not an endorsement.